{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:45:23Z","timestamp":1793756723842,"version":"4.6.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["00098892"],"award-info":[{"award-number":["00098892"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CZ.02.1.01\/0.0\/0.0\/16_019\/0000868"],"award-info":[{"award-number":["CZ.02.1.01\/0.0\/0.0\/16_019\/0000868"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s10620-020-06652-1","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T02:02:27Z","timestamp":1602813747000},"page":"3263-3269","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Importance of Hepcidin in the Etiopathogenesis of Anemia in Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9580-2302","authenticated-orcid":false,"given":"Eva","family":"Karaskova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Pospisilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Velganova-Veghova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milos","family":"Geryk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Volejnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dusan","family":"Holub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Hajduch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,16]]},"reference":[{"key":"6652_CR1","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1586\/eci.10.46","volume":"6","author":"A Bousvaros","year":"2010","unstructured":"Bousvaros A. Use of immunomodulators and biologic therapies in children with inflammatory bowel disease. Expert Rev Clin Immunol. 2010;6:659\u2013666.","journal-title":"Expert Rev Clin Immunol"},{"key":"6652_CR2","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.3748\/wjg.v24.i25.2741","volume":"24","author":"J S\u00fdkora","year":"2018","unstructured":"S\u00fdkora J, Pomaha\u010dov\u00e1 R, Kreslov\u00e1 M, et al. Current global trends in the incidence of pediatric-onset inflammatory bowel disease. World J Gastroenterol.. 2018;24:2741\u20132763.","journal-title":"World J Gastroenterol."},{"key":"6652_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.14735\/amgh201711","volume":"71","author":"J Bronsk\u00fd","year":"2017","unstructured":"Bronsk\u00fd J, Ber\u00e1nkov\u00e1 K, \u010cern\u00e1 Z, et al. Doporu\u010den\u00ed Pracovn\u00ed skupiny d\u011btsk\u00e9 gastroenterologie a v\u00fd\u017eivy \u010cPS pro diagnostiku a l\u00e9\u010dbu nespecifick\u00fdch st\u0159evn\u00edch z\u00e1n\u011bt\u016f u d\u011bt\u00ed \u2013 dopln\u011bk\u00a0k 1. vyd\u00e1n\u00ed. Gastroent Hepatol. 2017;71:11\u201318.","journal-title":"Gastroent Hepatol"},{"key":"6652_CR4","first-page":"4","volume":"67","author":"M Adamcov\u00e1","year":"2012","unstructured":"Adamcov\u00e1 M, Bajer M, Bajerov\u00e1 K, et al. Doporu\u010den\u00ed Pracovn\u00ed skupiny d\u011btsk\u00e9 gastroenterologie a v\u00fd\u017eivy p\u0159i \u010cPS pro diagnostiku a l\u00e9\u010dbu nespecifick\u00fdch st\u0159evn\u00edch z\u00e1n\u011bt\u016f u d\u011bt\u00ed. \u010ces-slov Pediat. 2012;67:4.","journal-title":"\u010ces-slov Pediat"},{"key":"6652_CR5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.crohns.2011.12.001","volume":"6","author":"AE Wiskin","year":"2012","unstructured":"Wiskin AE, Fleming BJ, Wootton SA, et al. Anaemia and iron deficiency in children with inflammatory bowel disease. J Crohns Colitis. 2012;6:687\u2013691.","journal-title":"J Crohns Colitis"},{"key":"6652_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/01.MIB.0000196646.64615.db","volume":"12","author":"CW Wells","year":"2006","unstructured":"Wells CW, Lewis S, Barton JR, et al. Effects of changes in haemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis. 2006;12:123\u2013130.","journal-title":"Inflamm Bowel Dis"},{"key":"6652_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s11938-018-0174-2","volume":"16","author":"D Patel","year":"2018","unstructured":"Patel D, Trivedi C, Khan N. Management of anemia in patients with Inflammatory Bowel Disease (IBD). Curr Treat Options Gastroenterol. 2018;16:112\u2013128.","journal-title":"Curr Treat Options Gastroenterol"},{"key":"6652_CR8","first-page":"51","volume":"37","author":"DF Wallace","year":"2016","unstructured":"Wallace DF. The regulation of iron absorption and homeostasis. Clin Biochem Rev. 2016;37:51\u201362.","journal-title":"Clin Biochem Rev"},{"key":"6652_CR9","doi-asserted-by":"crossref","unstructured":"Ganz T. Iron and infection [published correction appears in Int J Hematol. 2017 Dec 2]. Int J Hematol. 2018;107:7\u201315.","DOI":"10.1007\/s12185-017-2366-2"},{"key":"6652_CR10","unstructured":"Camaschella C. Regulation of iron balance. https:\/\/www.uptodate.com\/contents\/regulation-of-iron-balance. Accessed 9 Apr 2020."},{"key":"6652_CR11","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1016\/j.lpm.2017.10.006","volume":"46","author":"R Daher","year":"2017","unstructured":"Daher R, Manceau H, Karim Z. Iron metabolism and the role of the iron-regulating hormone hepcidin in health and disease. Presse Med. 2017;46:e272\u2013e278.","journal-title":"Presse Med"},{"key":"6652_CR12","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/ki.2009.357","volume":"76","author":"Y Cui","year":"2009","unstructured":"Cui Y, Wu Q, Zhou Y. Iron-refractory iron deficiency anemia: new molecular mechanisms. Kidney Int. 2009;76:1137\u20131141.","journal-title":"Kidney Int"},{"key":"6652_CR13","doi-asserted-by":"publisher","first-page":"7806","DOI":"10.1074\/jbc.M008922200","volume":"276","author":"CH Park","year":"2001","unstructured":"Park CH, Valore EV, Waring AJ, et al. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276:7806\u20137810.","journal-title":"J Biol Chem"},{"key":"6652_CR14","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1097\/MIB.0000000000001245","volume":"23","author":"P Krawiec","year":"2017","unstructured":"Krawiec P, Mroczkowska-Juchkiewicz A, Pac-Ko\u017cuchowska E. Serum hepcidin in children with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2017;23:2165\u20132171.","journal-title":"Inflamm Bowel Dis"},{"key":"6652_CR15","doi-asserted-by":"publisher","first-page":"936","DOI":"10.5604\/17322693.1111365","volume":"68","author":"P Krawiec","year":"2014","unstructured":"Krawiec P, Pac-Kozuchowska E. The role of hepcidin in iron metabolism in inflammatory bowel diseases. Postepy Hig Med Dosw (Online). 2014;68:936\u2013943.","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"6652_CR16","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1182\/blood-2017-11-737411","volume":"131","author":"C Casu","year":"2018","unstructured":"Casu C, Nemeth E, Rivella S. Hepcidin agonists as therapeutic tools. Blood. 2018;131:1790\u20131794.","journal-title":"Blood"},{"key":"6652_CR17","first-page":"9394060","volume":"2018","author":"A Dignass","year":"2018","unstructured":"Dignass A, Farrag K, Stein J. Limitations of serum ferritin in diagnosing iron deficiency in inflammatory conditions. Int J Chronic Dis. 2018;2018:9394060.","journal-title":"Int J Chronic Dis"},{"key":"6652_CR18","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1097\/MIB.0b013e31829a6e43","volume":"19","author":"G Bergamaschi","year":"2013","unstructured":"Bergamaschi G, Di Sabatino A, Albertini R, et al. Serum hepcidin in inflammatory bowel diseases: biological and clinical significance. Inflamm Bowel Dis. 2013;19:2166\u20132172.","journal-title":"Inflamm Bowel Dis"},{"key":"6652_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.21037\/tgh.2019.11.15","volume":"5","author":"A Piperno","year":"2020","unstructured":"Piperno A, Pelucchi S, Mariani R. Inherited iron overload disorders. Transl Gastroenterol Hepatol. 2020;5:25. https:\/\/doi.org\/10.21037\/tgh.2019.11.15.","journal-title":"Transl Gastroenterol Hepatol"},{"key":"6652_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.tracli.2017.06.015","volume":"24","author":"R Daher","year":"2017","unstructured":"Daher R, Karim Z. Iron metabolism: state of the art. Transfus Clin Biol. 2017;24:115\u2013119.","journal-title":"Transfus Clin Biol"},{"key":"6652_CR21","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1182\/blood-2010-06-287292","volume":"117","author":"AS Zhang","year":"2011","unstructured":"Zhang AS, Anderson SA, Wang J, et al. Suppression of hepatic hepcidin expression in response to acute iron deprivation is associated with an increase of matriptase-2 protein. Blood. 2011;117:1687\u20131699.","journal-title":"Blood"},{"key":"6652_CR22","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.3324\/haematol.2009.010322","volume":"94","author":"JJ Kroot","year":"2009","unstructured":"Kroot JJ, Kemna EH, Bansal SS, et al. Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica. 2009;94:1748\u20131752.","journal-title":"Haematologica"},{"key":"6652_CR23","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1373\/clinchem.2016.256768","volume":"62","author":"LN van der Vorm","year":"2016","unstructured":"van der Vorm LN, Hendriks JC, Laarakkers CM, et al. Toward worldwide hepcidin assay harmonization: identification of a commutable secondary reference material. Clin Chem. 2016;62:993\u20131001.","journal-title":"Clin Chem"},{"key":"6652_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cca.2013.04.021","volume":"423","author":"F Wolff","year":"2013","unstructured":"Wolff F, Deleers M, Melot C, et al. Hepcidin-25: Measurement by LC\u2013MS\/MS in serum and urine, reference ranges and urinary fractional excretion. Clin Chim Acta. 2013;423:99\u2013104.","journal-title":"Clin Chim Acta"},{"key":"6652_CR25","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1182\/blood-2011-02-337907","volume":"117","author":"TE Galesloot","year":"2011","unstructured":"Galesloot TE, Vermeulen SH, Geurts-Moespot AJ, et al. Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood. 2011;117:e218\u2013e225.","journal-title":"Blood"},{"key":"6652_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/jcla.21719","volume":"29","author":"T Sdogou","year":"2015","unstructured":"Sdogou T, Tsentidis C, Gourgiotis D, et al. Immunoassay-based serum hepcidin reference range measurements in healthy children: differences among age groups. J Clin Lab Anal. 2015;29:10\u201314.","journal-title":"J Clin Lab Anal"},{"key":"6652_CR27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/pr.2014.109","volume":"76","author":"L Uijterschout","year":"2014","unstructured":"Uijterschout L, Swinkels DW, Domell\u00f6f M, et al. Serum hepcidin measured by immunochemical and mass-spectrometric methods and their correlation with iron status indicators in healthy children aged 0.5\u20133 years. Pediatr Res. 2014;76:409\u2013414.","journal-title":"Pediatr Res"},{"key":"6652_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/ejh.12081","volume":"90","author":"G Cangemi","year":"2013","unstructured":"Cangemi G, Pistorio A, Miano M, et al. Diagnostic potential of hepcidin testing in pediatrics. Eur J Haematol. 2013;90:323\u2013330.","journal-title":"Eur J Haematol"},{"key":"6652_CR29","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/MEG.0b013e328343b885","volume":"23","author":"P Oustamanolakis","year":"2011","unstructured":"Oustamanolakis P, Koutroubakis IE, Messaritakis I, et al. Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2011;23:262\u2013268.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"6652_CR30","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.crohns.2014.04.008","volume":"8","author":"I Mecklenburg","year":"2014","unstructured":"Mecklenburg I, Reznik D, Fasler-Kan E, et al.; Swiss IBD Cohort Study Group. Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease. J Crohns Colitis. 2014;8:1392\u20131397.","journal-title":"J Crohns Colitis"},{"key":"6652_CR31","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/ecco-jcc\/jjv242","volume":"10","author":"M Martinelli","year":"2016","unstructured":"Martinelli M, Strisciuglio C, Alessandrella A, et al. Serum hepcidin and iron absorption in paediatric inflammatory bowel disease. J Crohns Colitis. 2016;10:566\u2013574.","journal-title":"J Crohns Colitis"},{"key":"6652_CR32","doi-asserted-by":"publisher","first-page":"e2308","DOI":"10.1097\/MD.0000000000002308","volume":"95","author":"S Bonovas","year":"2016","unstructured":"Bonovas S, Fiorino G, Allocca M, et al. Intravenous versus oral iron for the treatment of anemia in Inflammatory Bowel Disease: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2016;95:e2308.","journal-title":"Medicine (Baltimore)"},{"key":"6652_CR33","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1080\/00365520510023198","volume":"40","author":"K Erichsen","year":"2005","unstructured":"Erichsen K, Ulvik RJ, Nysaeter G, et al. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scand J Gastroenterol.. 2005;40:1058\u20131065.","journal-title":"Scand J Gastroenterol."},{"key":"6652_CR34","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3324\/haematol.2019.232124","volume":"105","author":"C Camaschella","year":"2020","unstructured":"Camaschella C, Nai A, Silvestri L. Iron metabolism and iron disorders revisited in the hepcidin era. Haematologica.. 2020;105:260\u2013272.","journal-title":"Haematologica."},{"key":"6652_CR35","doi-asserted-by":"publisher","DOI":"10.7754\/clin.lab.2019","author":"A Aksan","year":"2019","unstructured":"Aksan A, Wohlrath M, Iqbal TH, et al. Serum hepcidin levels predict intestinal iron absorption in patients with Inflammatory Bowel Disease. Clin Lab. 2019. https:\/\/doi.org\/10.7754\/clin.lab.2019.","journal-title":"Clin Lab"},{"key":"6652_CR36","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.blre.2017.02.004","volume":"31","author":"C Camaschella","year":"2017","unstructured":"Camaschella C. New insights into iron deficiency and iron deficiency anemia. Blood Rev. 2017;31:225\u2013233.","journal-title":"Blood Rev"},{"key":"6652_CR37","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1023\/a:1005437331967","volume":"45","author":"R Reifen","year":"2000","unstructured":"Reifen R, Matas Z, Zeidel L, et al. Iron supplementation may aggravate inflammatory status of colitis in a rat model. Dig Dis Sci. 2000;45:394\u2013397. https:\/\/doi.org\/10.1023\/a:1005437331967.","journal-title":"Dig Dis Sci"},{"key":"6652_CR38","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1046\/j.1365-2036.2001.01113.x","volume":"15","author":"J Carrier","year":"2001","unstructured":"Carrier J, Aghdassi E, Platt I, et al. Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment Pharmacol Ther. 2001;15:1989\u20131999.","journal-title":"Aliment Pharmacol Ther"},{"key":"6652_CR39","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.3945\/ajcn.110.004564","volume":"92","author":"MB Zimmermann","year":"2010","unstructured":"Zimmermann MB, Chassard C, Rohner F, et al. The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d\u2019Ivoire. Am J Clin Nutr. 2010;92:1406\u20131415.","journal-title":"Am J Clin Nutr"},{"key":"6652_CR40","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1136\/gutjnl-2015-309940","volume":"66","author":"T Lee","year":"2017","unstructured":"Lee T, Clavel T, Smirnov K, et al. Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017;66:863\u2013871.","journal-title":"Gut"},{"key":"6652_CR41","doi-asserted-by":"publisher","first-page":"e0117383","DOI":"10.1371\/journal.pone.0117383","volume":"10","author":"Z Tolkien","year":"2015","unstructured":"Tolkien Z, Stecher L, Mander AP, et al. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One.. 2015;10:e0117383.","journal-title":"PLoS One."},{"key":"6652_CR42","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.crohns.2011.09.010","volume":"6","author":"TW Lee","year":"2012","unstructured":"Lee TW, Kolber MR, Fedorak RN, et al. Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis. J Crohns Colitis. 2012;6:267\u2013275.","journal-title":"J Crohns Colitis"},{"key":"6652_CR43","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/jpc.14093","volume":"54","author":"E Karaskova","year":"2018","unstructured":"Karaskova E, Volejnikova J, Holub D, et al. Hepcidin in newly diagnosed inflammatory bowel disease in children. J Paediatr Child Health. 2018;54:1362\u20131367.","journal-title":"J Paediatr Child Health"},{"key":"6652_CR44","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/jpc.14593","volume":"56","author":"E Karaskova","year":"2020","unstructured":"Karaskova E, Volejnikova J, Holub D, et al. Changes in serum hepcidin levels in children with inflammatory bowel disease during anti-inflammatory treatment. J Paediatr Child Health.. 2020;56:276\u2013282.","journal-title":"J Paediatr Child Health."},{"key":"6652_CR45","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/ecco-jcc\/jjz056","volume":"13","author":"H Moran-Lev","year":"2019","unstructured":"Moran-Lev H, Galai T, Yerushalmy-Feler A, et al. Vitamin D decreases hepcidin and inflammatory markers in newly diagnosed Inflammatory Bowel Disease Paediatric patients: a prospective study. J Crohns Colitis.. 2019;13:1287\u20131291.","journal-title":"J Crohns Colitis."},{"key":"6652_CR46","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1681\/ASN.2013040355","volume":"25","author":"J Bacchetta","year":"2014","unstructured":"Bacchetta J, Zaritsky JJ, Sea JL, et al. Suppression of iron-regulatory hepcidin by vitamin D. J Am Soc Nephrol.. 2014;25:564\u2013572.","journal-title":"J Am Soc Nephrol."},{"key":"6652_CR47","doi-asserted-by":"publisher","first-page":"6843976","DOI":"10.1155\/2017\/6843976","volume":"2017","author":"F Cavallaro","year":"2017","unstructured":"Cavallaro F, Duca L, Pisani LF, et al. Anti-TNF-mediated modulation of prohepcidin improves iron availability in Inflammatory Bowel Disease, in an IL-6-mediated fashion. Can J Gastroenterol Hepatol. 2017;2017:6843976.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"6652_CR48","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/MPG.0000000000001650","volume":"66","author":"MA Atkinson","year":"2018","unstructured":"Atkinson MA, Leonard MB, Herskovitz R, et al. Changes in hepcidin and hemoglobin after anti-TNF-alpha therapy in children and adolescents with crohn disease. J Pediatr Gastroenterol Nutr. 2018;66:90\u201394.","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06652-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-020-06652-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06652-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T12:27:47Z","timestamp":1634387267000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-020-06652-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,16]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["6652"],"URL":"https:\/\/doi.org\/10.1007\/s10620-020-06652-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,16]]},"assertion":[{"value":"9 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}